Stay updated on Combination Immunotherapy in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Combination Immunotherapy in Prostate Cancer Clinical Trial page.

Latest updates to the Combination Immunotherapy in Prostate Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check38 days agoChange DetectedThe page has updated its dates and location details, with a new postal code for Porto Alegre, Brazil, and the removal of outdated dates.SummaryDifference0.9%
- Check45 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check52 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check67 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
- Check74 days agoChange DetectedThe study on the safety and efficacy of nivolumab in combination with other treatments for castration-resistant prostate cancer has been updated with new dates and a revised version, indicating ongoing research developments.SummaryDifference1%
Stay in the know with updates to Combination Immunotherapy in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Immunotherapy in Prostate Cancer Clinical Trial page.